A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopic biopsy specimens

Annals of Surgery

Volumn 226, Issue 1, 1997, Pages 35-42

  Nakamura, Mitsunari ^a   Katano, Mitsuo ^a   Fujimoto, Kazuma ^a   Morisaki, Takashi ^b  

^a SAGA UNIVERSITY   (Japan)

^b Department of Surgery   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; COLLAGENASE; CYCLIN D1; CYCLIN E; INTERLEUKIN 10; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR A; TRANSFORMING GROWTH FACTOR BETA; UROKINASE; VASCULOTROPIN;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; ENDOSCOPIC BIOPSY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA;

BIOPSY; BLOTTING, SOUTHERN; CARCINOMA; DNA PRIMERS; GASTRIC MUCOSA; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; STOMACH; STOMACH NEOPLASMS;

EID: 0030728242     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199707000-00005     Document Type: Article

References (47)

1. Dupont JB, Lee JR, Burton GR, Cohn I. Adenocarcinoma of the stomach: review of 1497 cases. Cancer 1978; 41:941-947.
2. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:1287-1291.
3. Maruyama K, Gunven P, Okabayashi K, et al. Lymph node metastasis of gastric cancer: general pattern in 1931 patients. Ann Surg 1989; 210:596-602.
4. Jatzko GR, Lisborg PH, Denk H, et al. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer 1995; 76:1302-1312.
5. Tada M, Murakami A, Karita M, et al. Endoscopic resection of early gastric cancer. Endoscopy 1993; 25:445-450.
6. Ichikura T, Uefuji K, Tomimatsu S, et al. Surgical strategy for patients with gastric carcinoma with submucosal invasion: a multivariate analysis. Cancer 1995; 76:935-940.
7. Hunt TK. The physiology of wound healing. Ann Emerg Med 1988; 17:1265-1273.
8. Deuel TF. Polypeptide growth factor: roles in normal and abnormal cell growth. Ann Rev Cell Biol 1987; 3:443-462.
9. Daughaday WH, Duel TF. Tumor secretion of growth factors. Endocrinol Metab Clin North Am 1991; 20:539-563.
10. Doherty AJP, Cocked MI, Birch ML, et al. Gelatinase inhibitors for the treatment of cancer. Clin Exp Metastasis 1994; 12:12.
11. Hart IR, Saini A. Biology of tumour metastasis. Lancet 1992; 339:1453-1457.
12. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angeogenesis suppresses tumor growth in vivo. Nature 1993; 362:841-844.
13. Silver BJ. Platelet-derived growth factor in human malignancy. Biofactors 1992; 3:217-227.
14. Ciardiello F, Kim N, McGeady ML, et al. Expression of transforming growth factor alpha (TGF-α) in breast cancer. Ann Oncol 1991; 2:169-182.
15. Hinds PW, Dowdy SF, Hg Eaton E, et al. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A 1994; 91:709-713.
16. Wang TC, Cardiff RD, Zukerberg L, et al. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994; 369:669-671.
17. Sulitzeanu D. Immunosuppressive factors in human cancer. Adv Cancer Res 1993; 60:247-267.
18. Toge T, Hamamoto S, Itagaki O, et al. Concanavalin-A induced and spontaneous suppression cell activity in peripheral blood lymphocytes and spleen cells from gastric cancer patients. Cancer 1983; 52:1624-1630.
19. Friess H, Yamanaka Y, Buchler M. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer: correlation with decreased survival. Gastroenterology 1993; 105:1846-1856.
20. Kruger-Krasagakes S, Krasagakis K, Garbe C, et al. Expression of interleukin 10 in human melanoma. Br J Cancer 1994; 70:1182-1185.
21. Albino AP, Nanus DM, Mentle IR, et al. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene 1989; 4:1363-1374.
22. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. Tokyo: Kanehara and Company, 1995; 26-35.
23. Chromeznski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Annal Biochem 1987; 162:156-159.
24. Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin Cell 1991; 65:691-699.
25. Koff A, Cross F, Fisher A, et al. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 1991; 66:1217-1228.
26. Schwartz GK, Wang H, Lampen N, et al. Defining the invasive phenotype of proximal gastric cancer cells. Cancer 1994; 73:22-27.
27. Keck P, Hauser S, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246:1309-1312.
28. Albino AP, Davis BM, Nanus DM. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res 1991; 51:4815-4820.
29. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective response to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254:277-279.
30. Sano T, Kobori O, Muto T. Lymph-node metastasis from early gastric cancer: endoscopic resection of tumour. Be J Surg 1992; 79:241-244.
31. Noguchi Y, Imada T, Matsumoto T, et al. Radical surgery for gastric cancer: a review of the Japanese experience. Cancer 1989; 64:2053-2062.
32. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radically. World J Surg 1987; 11:418-425.
33. Jaehne J, Meyer HJ, Maschek H, et al. Lymphadenectomy in gastric carcinoma. Arch Surg 1992; 127:290-294.
34. Shiu MH, Moore E, Sanders M. Influence of the extent of resection on survival after curative treatment of gastric carcinoma. Arch Surg 1987; 122:1347-1351.
35. Eriguchi M, Miyamoto Y, Fujii Y, et al. Regional lymph node metastasis of early gastric cancer. Eur J Surg 1991; 157:197-200.
36. Moreaux J, Bougaran J. Early gastric cancer: a 25-year-surgical experience. Ann Surg 1993; 217:347-355.
37. Hayashi N, Ito I, Yanagisawa A, et al. Genetic diagnosis of lymphnode metastasis in colorectal cancer. Lancet 1995; 345:1257-1259.
38. Muller D, Millon R, Lidereau R, et al. Frequent amplification of 11q 13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur J Cancer 1994; 2:113-120.
39. Akama Y, Yasui W, Yokozaki H, et al. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 1995; 86:617-621.
40. Yonemura Y, Nojima N, Kaji M, et al. E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer 1995; 76:941-953.
41. Yamagata S, Yoshii Y, Suh JG, et al. Occurrence of an active form of gelatinase in human gastric and colorectal carcinoma tissues. Cancer Lett 1991; 59:51-55.
42. Nomura H, Sato H, Seiki M, et al. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 1995; 55:3263-3266.
43. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986; 46:155-169.
44. Ariad S, Seymour L, Bezwoda WR. Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: correlation with stage and rate of progression. Breast Cancer Res Treat 1991; 20:11-17.
45. Seymour L, Dajee D, Bezwoda WR. Tissue platelet derived growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer. Breast Cancer Res Treat 1993; 26:247-252.
46. Anan K, Morisaki T, Katano M, et al. VEGF and PDGF are potential angiogenic and metastatic factors in human breast cancer. Surgery 1996; 119:333-339.
47. Oya M, Yao T, Nagai E, Tsuneyoshi M. Metastasizing intramucosal gastric carcinomas: well-differentiated type and proliferative activity using proliferative cell nuclear antigen are Ki-67. Cancer 1995; 75:926-935.